Industry event: case study discussion on patients eligible for an immunotherapy delivered subcutaneo

When:  Mar 4, 2026 from 18:00 to 20:30 (ET)
Associated with  Ann Arbor
Please join:
Krzysztof Misiukiewicz, MD
For the event:
Case Study Discussion on Patients Eligible for an Immunotherapy Administered Subcutaneously
Learning Objectives:
Review clinical trial data for an immunotherapy administered subcutaneously
Discuss considerations regarding subcutaneous administration and appropriate patients for this treatment option
Speaker:
Krzysztof Misiukiewicz, MD
Krzysztof Misiukiewicz, MD is an Associate Professor of Medicine (Hematology/Medical Oncology) at the Icahn School of Medicine at Mount Sinai, the Clinical Director for the Center for Personalized Cancer Therapeutics, and the Chairman of the Oncology Pharmacy & Therapeutics Committee at Mount Sinai Hospital. He attended Medical Academy in Wroclaw, Poland and completed his residency in internal medicine at St. Barnabas Medical Center and fellowship training in hematology and oncology at Mt. Sinai. He is board certified in internal medicine, hematology, and medical oncology. Dr. Misiukiewicz's clinical expertise includes medical management of head and neck and thyroid cancer. His research investigates new ways to combine traditional treatments such as chemotherapy and radiotherapy with targeted agents and immunotherapy and he is co-author or author of medical textbook chapters and articles in peer-reviewed journals including Annals of Medicine and the Journal of Clinical Oncology.
 
Date/Start time:
3/4/2026, 6:00 PM
Date/End time:
3/4/2026, 8:30 PM
Venue
1919 S Industrial Hwy
Ann Arbor, MI 48105

Location

Venue
1919 S Industrial Hwy
Ann Arbor, MI 48105

Contact

Tara Shantz
6146343937
tara.shantz@merck.com